Unraveling the mystery: a Mendelian randomized exploration of gut microbiota and different types of obesity

被引:2
作者
Liu, Siyuan [1 ]
Li, Fan [2 ]
Cai, Yunjia [1 ]
Ren, Linan [1 ]
Sun, Lin [1 ]
Gang, Xiaokun [1 ]
Wang, Guixia [1 ]
机构
[1] First Hosp Jilin Univ, Dept Endocrinol & Metab, Changchun, Jilin, Peoples R China
[2] First Hosp Jilin Univ, Dept Gastroenterol, Changchun, Jilin, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2024年 / 14卷
关键词
gut microbiota; obesity; Mendelian randomization; causal relationship; stratification; CHAIN FATTY-ACIDS; BODY-MASS INDEX; GENETIC-VARIANTS; ENERGY-BALANCE; HOST GENETICS; HEALTH; INTERPLAY; BUTYRATE; DIET;
D O I
10.3389/fcimb.2024.1352109
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Numerous studies have demonstrated the influence of gut microbiota on the development of obesity. In this study, we utilized Mendelian randomization (MR) analysis to investigate the gut microbiota characteristics among different types of obese patients, aiming to elucidate the underlying mechanisms and provide novel insights for obesity treatment. Methods Two-sample multivariable Mendelian randomization (MR) analysis was employed to assess causal relationships between gut microbiota and various obesity subtypes. Gut microbiota data were obtained from the international consortium MiBioGen, and data on obese individuals were sourced from the Finnish National Biobank FinnGen. Eligible single-nucleotide polymorphisms (SNPs) were selected as instrumental variables. Various analytical methods, including inverse variance weighted (IVW), MR-Egger regression, weighted median, MR-RAPS, and Lasso regression, were applied. Sensitivity analyses for quality control included MR-Egger intercept tests, Cochran's Q tests, and leave-one-out analyses and others. Results Mendelian randomization studies revealed distinct gut microbiota profiles among European populations with different obesity subtypes. Following multivariable MR analysis, we found that Ruminococcaceae UCG010 [Odds Ratio (OR): 0.842, 95% confidence interval (CI): 0.766-0.926, Adjusted P value: 0.028] independently reduced the risk of obesity induced by excessive calorie intake, while Butyricimonas [OR: 4.252, 95% CI: 2.177-8.307, Adjusted P value: 0.002] independently increased the risk of medication-induced obesity. For localized adiposity, Pasteurellaceae [OR: 0.213, 95% CI: 0.115-0.395, Adjusted P value: <0.001] acted as a protective factor. In the case of extreme obesity with alveolar hypoventilation, lactobacillus [OR: 0.724, 95% CI: 0.609-0.860, Adjusted P value: 0.035] reduced the risk of its occurrence. Additionally, six gut microbiota may have potential roles in the onset of different types of obesity. Specifically, the Ruminococcus torques group may increase the risk of its occurrence. Desulfovibrio and Catenabacterium may serve as protective factors in the onset of Drug-induced obesity. Oxalobacteraceae, Actinomycetaceae, and Ruminiclostridium 9, on the other hand, could potentially increase the risk of Drug-induced obesity. No evidence of heterogeneity or horizontal pleiotropy among SNPs was found in the above studies (all P values for Q test and MR-Egger intercept > 0.05). Conclusion Gut microbiota abundance is causally related to obesity, with distinct gut microbiota profiles observed among different obesity subtypes. Four bacterial species, including Ruminococcaceae UCG010, Butyricimonas, Pasteurellaceae and lactobacillus independently influence the development of various types of obesity. Probiotic and prebiotic supplementation may represent a novel approach in future obesity management.
引用
收藏
页数:11
相关论文
共 57 条
  • [1] ICD-11
    不详
    [J]. LANCET, 2019, 393 (10188) : 2275 - 2275
  • [2] Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies
    Aron-Wisnewsky, Judith
    Warmbrunn, Moritz V.
    Nieuwdorp, Max
    Clement, Karine
    [J]. GASTROENTEROLOGY, 2021, 160 (02) : 573 - 599
  • [3] The gut microbiota as an environmental factor that regulates fat storage
    Bäckhed, F
    Ding, H
    Wang, T
    Hooper, LV
    Koh, GY
    Nagy, A
    Semenkovich, CF
    Gordon, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15718 - 15723
  • [4] Gut microbiota and energy balance: role in obesity
    Blaut, Michael
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2015, 74 (03) : 227 - 234
  • [5] Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic
    Bowden, Jack
    Del Greco, Fabiola M.
    Minelli, Cosetta
    Smith, George Davey
    Sheehan, Nuala A.
    Thompson, John R.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2016, 45 (06) : 1961 - 1974
  • [6] Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
    Bowden, Jack
    Smith, George Davey
    Haycock, Philip C.
    Burgess, Stephen
    [J]. GENETIC EPIDEMIOLOGY, 2016, 40 (04) : 304 - 314
  • [7] Burgess Stephen, 2019, Wellcome Open Res, V4, P186, DOI 10.12688/wellcomeopenres.15555.1
  • [8] A review of instrumental variable estimators for Mendelian randomization
    Burgess, Stephen
    Small, Dylan S.
    Thompson, Simon G.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (05) : 2333 - 2355
  • [9] Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x
  • [10] Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283